Clinical Evidence: Heart Attack and Stroke Risk Reduction The SUSTAIN-6 trial, which followed over 3,000 people with type 2 diabetes and existing heart disease or high cardiovascular risk, found that semaglutide reduced the combined risk of heart attack, stroke, and cardiovascular death by 26% compared to placebo
Ectoin acts as a powerful barrier defender to calm stressed, sensitive skin and reinforce the skins natural moisture barrier against external irritants
S.ZhangJ.et al
10.1038/s41398-020-01097-6 38
The substance contains glycine, cysteine, and glutamic acid, essential amino acids produced by the liver and involved in numerous body processes
Thanks to its unique composition, it provides energy, reduces fatigue and is ideal during weight reduction diets or after sports, when the body loses important minerals